Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.9259
-0.0147 (-1.56%)
At close: Jul 24, 2026, 4:00 PM EDT
0.9190
-0.0069 (-0.75%)
After-hours: Jul 24, 2026, 7:58 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $13.71 million as of July 24, 2026. Its market cap has decreased by -46.33% in one year.
Market Cap
13.71M
Enterprise Value
19.76M
1-Year Change
-46.33%
Ranking
Category
Stock Price
$0.93
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $13.71M, a decrease of -84.53%. That is a compound annual growth rate of -30.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 13.71M | -3.05% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 15.60M |
| Cyclerion Therapeutics | 15.31M |
| OSR Health | 15.19M |
| SeaStar Medical Holding | 15.14M |
| Moolec Science | 15.08M |
| Vyome Holdings | 14.88M |
| Citius Pharmaceuticals | 14.60M |
| Lexaria Bioscience | 14.38M |